STING1 and cancer: Chronic activation of STING has been implicated in various inflammatory conditions, including autoimmune diseases and cancer.[63] It is possible that DNA damage and STING activation caused by TkeA could potentially contribute to disease progression and increase the risk of carcinogenesis.